Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.

Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hägglund H, Mattsson J, Uhlin M.

Cent Eur J Immunol. 2019;44(1):84-91. doi: 10.5114/ceji.2018.75831. Epub 2019 Apr 15.

2.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H.

Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2.

3.

High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis.

Remberger M, Afram G, Sundin M, Uhlin M, LeBlanc K, Björklund A, Mattsson J, Ljungman P.

Bone Marrow Transplant. 2016 Nov;51(11):1518-1521. doi: 10.1038/bmt.2016.159. Epub 2016 Jun 6. No abstract available.

PMID:
27272449
4.

Evaluation of prognostic factors among patients with chronic graft-versus-host disease.

Pérez-Simón JA, Afram G, Martino R, Piñana JL, Caballero-Velazquez T, Ringden O, Valcarcel D, Caballero D, Remberger M, de Paz Y, Sierra J, Miguel JS, Hagglund H.

Haematologica. 2012 Aug;97(8):1187-95. doi: 10.3324/haematol.2011.055244. Epub 2012 Feb 27.

Supplemental Content

Support Center